RETRACTED: REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns

Cell Signal. 2010 Oct;22(10):1485-94. doi: 10.1016/j.cellsig.2010.05.017. Epub 2010 Jun 4.

Abstract

In the classic view interleukin-13 (IL-13) binds to a heterodimer protein complex of the IL-13Ralpha1 and IL-4Ralpha chains and signals through a Janus kinase 1 (JAK1)-signal transducer and activator of transcription 6 (STAT6) mechanism. We recently reported that IL-13 also signals through the IL-13Ralpha2 chain initiating all three mitogen activated protein kinase (MAPK) pathways, and the relative expression of IL-13Ralpha1 and IL-13Ralpha2 modulates one another's transduction pathway. Therefore we investigated whether generation of reactive oxygen species (ROS) as second messengers may serve as a common nexus between these two pathways emanating from the individual IL-13 receptor chains in intestinal epithelial cells (IEC). IL-13 stimulates intracellular ROS synthesis within 5min via IL-13Ralpha1-JAK1-STAT6- and IL-13Ralpha2-MEK1/2-ERK1/2-dependent activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-1 (NOX-1). IL-13-induced ROS generation in turn positively regulates phosphorylation of ERK1/2 and STAT6, yielding a feed forward amplification loop. IL-13 also stimulates the stable, long-term gene expression of two other NADPH oxidases, NOX-4 and DUOX-2, which along with constitutive NOX-1, might facilitate elevated, continuous production of ROS in IL-13-activated IEC. The contribution of each signal transduction pathway initiated by IL-13 engagement to such biological functions as wound healing, inflammation, and apoptosis was mapped for representative, responsive genes. Distinct usage patterns were observed, demonstrating not only that IL-13 signal transduction through STAT6, MAPK, and ROS is regulated in both an antagonistic and cyclic fashion, but also that each pathway plays a specific role in modulating the wound healing and anti-apoptotic capabilities of the intestinal epithelium.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Cell Line, Tumor
  • Dual Oxidases
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology
  • Epithelial Cells / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation*
  • Humans
  • Interleukin-13 / pharmacology*
  • Interleukin-13 Receptor alpha1 Subunit / metabolism
  • Interleukin-13 Receptor alpha2 Subunit / metabolism
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / enzymology
  • Intestinal Mucosa / metabolism*
  • Janus Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • NADPH Oxidase 1
  • NADPH Oxidase 4
  • NADPH Oxidases / biosynthesis
  • NADPH Oxidases / genetics
  • Oxidation-Reduction
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism*
  • Receptors, Interleukin-13 / metabolism
  • STAT6 Transcription Factor / metabolism
  • Second Messenger Systems*

Substances

  • Interleukin-13
  • Interleukin-13 Receptor alpha1 Subunit
  • Interleukin-13 Receptor alpha2 Subunit
  • RNA, Messenger
  • Reactive Oxygen Species
  • Receptors, Interleukin-13
  • STAT6 Transcription Factor
  • Dual Oxidases
  • NADPH Oxidase 1
  • NADPH Oxidase 4
  • NADPH Oxidases
  • NOX1 protein, human
  • NOX4 protein, human
  • DUOX2 protein, human
  • Janus Kinase 1
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinase Kinases